Anti-TNF therapies have demonstrated reasonable response rates for treating cutaneous manifestations, arthritis, and ocular EIMs in IBD, suggesting a role for TNF-dependent mechanisms in EIM pathophysiology. Here, TNF is linked to inflammatory bowel disease.